SecBot SecBot
8-K/A ·Filed Mar 27, 2026

PETVW

PetVivo Holdings, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed7mo ago SEC0001493152-26-013009
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

Monitor whether the company can secure the remaining $600,000 tranche by April 15 and the potential $1.5 million follow-on investment by June 30. The dilution from this offering and potential future issuance could pressure the stock price, especially given the speculative nature of the investment as disclosed in the filing.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

PetVivo Holdings raised $1 million in an unregistered private placement by issuing 1.25 million units at $0.80 per unit, with each unit consisting of one share of common stock and one warrant to purchase an additional share at $1.10. The company also granted the investor an option to invest up to an additional $1.5 million under the same terms by June 30, 2026. The proceeds will fund commercialization of its Spryng™ product, new product development, and general corporate purposes.

Key Financial Metrics

Deal Value
$1.0M

Key Facts

  • Raised $1 million through private placement of 1.25 million units at $0.80 per unit
  • Each unit consists of one common share and one warrant exercisable at $1.10 per share for 3 years
  • Investor received option to invest additional $1.5 million by June 30, 2026
  • Proceeds to fund Spryng™ commercialization, new product development, and working capital
  • Initial $400,000 received on March 13, 2026, with remaining $600,000 expected by April 15, 2026

Financial Impact

Immediate dilution from issuance of 1.25 million shares and warrants; potential for additional 1.875 million shares if option is exercised

dilutioncashequity

Risk Factors

  • Significant shareholder dilution from the issuance of 1.25 million shares and warrants
  • Additional dilution of up to 1.875 million shares if the investor exercises the option
  • Proceeds may not be sufficient to achieve commercial success of Spryng™ product

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K/A Filing (Primary)0001493152-26-013009
Document: form8-ka.htm0001493152-26-013009
Document: 0001493152-26-013009-index-headers.html0001493152-26-013009
Document: 0001493152-26-013009-index.html0001493152-26-013009
Document: 0001493152-26-013009.txt0001493152-26-013009
2 reports for PETVW
Performance horizon
Filters
Rows
Reports for PETVW — sortable, filterable
TypeNow
Apr 17, 2026
27w ago
8-K
BEARISH ★ 6/10
—awaiting T+20——
Mar 27, 2026
30w ago
8-K/A
BEARISH ★ 6/10
—awaiting T+20——
Showing 2 of 2

US Market Status

Market Closed — Opens Tue (17h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 27, 2026